Keyphrases
Sequence Data
100%
Somatic Variants
100%
Somatic mutation
100%
Targeted Deep Sequencing
100%
Exome
100%
Sequencing Depth
50%
Exome Sequencing
33%
Caller
33%
Molecular Diagnostics
16%
Seurat
16%
Indel Calling
16%
Enhanced Sensitivity
16%
Next-generation Sequencing
16%
High Sensitivity
16%
Pairwise Comparison
16%
Publicly Available
16%
High Robustness
16%
Tumor-normal
16%
Clinical Setting
16%
Cancer Tissue
16%
Sniper
16%
Comprehensive Evaluation
16%
Therapy Decision
16%
Small Deletion
16%
Single nucleotide Variant
16%
De Facto Standard
16%
Breast Cancer Patients
16%
Biochemistry, Genetics and Molecular Biology
Deep Sequencing
100%
Exome
100%
Somatic Mutation
100%
Exome Sequencing
50%
Indel
50%
Next Generation Sequencing
25%
Immunology and Microbiology
Exome
100%
Somatic Mutation
100%
Indel Mutation
50%
Whole Exome Sequencing
50%
Cancer Tissue
25%
Next Generation Sequencing
25%